Rafael Rivas-Santisteban

July 31, 2024

The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson’s and Alzheimer’s Disease Progression

Abstract The first objective is to highlight the lack of tools to measure whether a given intervention affords neuroprotection in…

June 18, 2024

Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke

Abstract Stroke is one of the leading causes of death. It not only affects adult people but also many children.…

April 10, 2024

Heteromers Formed by GPR55 and Either Cannabinoid CB1 or CB2 Receptors Are Upregulated in the Prefrontal Cortex of Multiple Sclerosis Patients

Abstract Multiple sclerosis (MS) is an autoimmune, inflammatory, and neurodegenerative disease of the central nervous system for which there is…

June 21, 2018

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

Abstract Cannabigerol (CBG) is one of the major phytocannabinoids present in Cannabis sativa L. that is attracting pharmacological interest because…

© 2026 cannabishub.eu